series-c-plus
Stage
2
Investors
About
Mitralign developed a minimally invasive medical device technology intended to treat mitral valve regurgitation by reshaping the mitral valve annulus.
Explore Mitralign's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.